Introduction
============

The Long QT syndrome (LQTS) can be inherited or acquired. Patients are predisposed to the ventricular tachyarrhythmia torsade de pointes (TdP) which causes syncope and sudden death ([@R1]). This syndrome is a prototype ion channel disease (channelopathies) and leads to abnormal electrical properties of the heart ([@R2], [@R3]). It should be mentioned that cardiac ion channels contain protein complexes in the sarcolemma of cardiomyocytes, through very regular opening and closing of the gates, a selective and rapid flow of ions is conducted through a central pore. Abnormalities in ion channel function can have disastrous consequences that manifest themselves as ECG abnormalities and arrhythmias ([@R4], [@R5]). While doing some exercises or having some feelings, a repolarization disorder named LQTS develops. This kind of disorder is characterized by extension of the QT intervals on the ECG which is indicated by syncopal episodes. The cause in 50% to 60% of the patients that suffer from this type of syndrome, is gene mutations which encode the subunits of ion channels. It seems highly probable that the inheritance pattern of LQT is polygenic which embraces both mtDNA and nuclear DNA genes ([@R6], [@R7]). It is a fact that heart is greatly dependent on oxidative energy which is generated in mitochondria, and ion channels are ATP-sensitive and exist in high density in the sarcolemma membrane ([@R8]). We have conducted our research on an Iranian family with LQTS and scrutinized mtDNA mutation among them. Although the exact mechanism of mitochondrial NNA and its impact on the syndrome is vague, it is probable that it might have a prominent etiological role.

Materials and Methods
=====================

Patients
--------

The study cases comprised a total of 18 members (11 females and 7 males) in a three-generation family (Figure [1A](#F1){ref-type="fig"}). The formula of Bazett was applied in order to assess the values of QTc ([@R9]). In the case study of the family, the patients were admitted presenting symptomatic with QTc of ≥450 ms and asymptomatic with QTc of ≥470 ms that were tabulated according to the effect. All of the family members who were involved in the research had granted the informed consent, and blood samples and clinical evaluations were taken from them. The ethics committee of Yazd University ratified the under protocols. Thirty individuals (including 14 females and 16 males) who had no connection with definitive diagnoses of mitochondrial or cardiac disorders were assigned as the control group. All of the participants (both patients and control group) were notified of the research objectives and granted their informed consents to the genetic analysis.

Patient P6 (Proband) was a man aged 62 with a prolonged QT interval (QTc501 ms), his palpitation and echocardiography results were normal. P1 was a woman aged about 71, who had a 520 ms QT interval. Seven children of this woman suffered from LQT3. P7 was a man who had had a sudden cardiac arrest and a 533 ms QT interval, and the patients P2 and P8 had syncopes, in this pedigree. The rest of the patients\' clinical manifestations are presented in Figure [1B](#F1){ref-type="fig"}.

Mutational analysis of mitochondrial genome
-------------------------------------------

Through a DNA extraction kit the total DNA was extracted from peripheral blood lymphocytes of all patients and the controls (DNAfast Kit-Genfanavaran, Tehran, Iran). PCR of each sample was set in a 0.5 ml tube using 100 ng of total DNA, 10 pM of each primer, 200 µM of dNTPs, 1X PCR buffer containing 2.5 mM MgCl~2~ and 1 U Taq DNA polymerase (Roche Diagnostics, Mannheim, Germany). After an initial 3 min denaturation at 94°C, 32 cycles were performed (94°C for 30 sec, 57°C for 45 sec and 72°C for 50 sec) followed by a final 5 min extension at 72°C. The samples were mixed with 10 µl denaturing/loading solution containing 95% formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol and heated at 95°C for 10 min and immediately chilled on ice. 5 µl of the PCR products were electrophoresed on an 8% nondenaturing acrylamide:bisacrylamide (62.5:1) gel in TAE buffer at 200 V; during electrophoresis, the temperature of the gel was constantly kept at 15°C for 16 hr. A strict control of the gel temperature is of extreme importance to obtain a proper determination of polymorphisms, as no resolution was obtained by running the gels at temperatures other than 15°C. SSCP bands were visualized on the gels by silver staining ([@R10]).

If a band shift was detected by SSCP, it was confirmed with direct DNA sequencing by using an ABI 3700 capillary sequencer. Five segments, ranging in size from approximately 110 to 446 bp, were amplified by PCR and assayed by SSCP in both groups. Table [1](#T1){ref-type="table"}, illustrates and defines respectively, the state of primers and PCR for SSCP analysis and sequencing, which were designed and optimized with Gene Runner version 3.05 (Hastings Software Inc. Hastings, NY, USA). These segments cover 40% of mtDNA, including the entire sequence of the 7 transfer RNA genes (tRNA^Lys,\ Gly,\ Arg,\ His,\ Ser,\ Leu\ and\ Glu^) and the sequences of 9 protein-coding genes (CoxII, ATPase8, ATPase6, CoxIII, ND3, ND4L, ND4, ND5, and ND6). The results of DNA sequence analysis were compared with the revised Cambridge sequence ([@R11], [@R12]) and differences were recorded as mutations. Each sequence variation was then checked against the Mitomap database ([@R13]). Those that were not recorded in the database were categorized as novel mtDNA variations.

Pathogenicity analysis
----------------------

The prediction of pathogenicity of amino acid changes was accomplished by the Sorting Intolerant from Tolerant (SIFT) database. SIFT score ranges from 0 to 1; the amino acid substitution is predicted damaging if the score is ≤ 0.05 and tolerated if the score is \> 0.05. The median score ranges from 0 to 4.32. Protean (Protein Structure Prediction and Annotation) identified the secondary structural features and physiochemical characteristics including hydropathy index, flexibility index and antigenic index; the conservation of the amino acid changes was assayed using the MEGALIGN program that is part of the Lasergene V.6 software (DNASTAR, Inc. Madison, WI, USA). The hydropathy index was measured by Protean according to the Kyte-Doolitle method ([@R14]), which predicts the regional hydropathy of proteins from their amino acid sequence. All amino acids were designated by hydropathy values and they were averaged about a window size equal to 9. Results below 0 are hydrophobic and above 0 are hydrophilic. tRNA sequence and the two-dimensional (2D) structure comparison was accomplished according to the Mamit-tRNA database (<http://mamit-tRNA.u-strasbg.fr>).

Data analysis
-------------

Data are presented as Mean±SD values. Frequen- cy data between normal controls and patients were compared using Pearson\'s chi-square test. To carry out statistical analysis, we have applied the GraphPad Prism software; *P* presents values below 0.05 which is indicative of statistical significance.

Results
=======

The age range of patients and controls were 4 to 71 (25.4±19.9, Mean±SD) and 12 to 61 (22.5±18.6, Mean±SD) years, respectively. The range of QTc of patients was 428 to 560 (489±39.2, Mean±SD). Statistics revealed that 10 patients had heart palpitation and 3 had syncopes.

SSCP analyses were carried out on 18 patients and 30 healthy controls. Normal controls of the same ethnicity were also genotyped to establish the frequency of mutations. DNA fragments showing abnormal banding patterns on SSCP analyses were sequenced for the identification of exact mutations (Figure [2](#F2){ref-type="fig"}).

A total of six different point mutations were detected in 14 related patients (P1, P2, P3, P4, P5, P6, P7, P8, P9, P10, P11, P12, P13, and P14 patients) (Table [2](#T2){ref-type="table"} ). These mutations were not found in P15, P16, P17, and P18 patients. This familial history of mutations \[4 novel mutations (m.8462 T\>C, m.8704 A\>C, m.9140 C\>G and m.10530 G\>A) and the indicator of maternal inheritance is 2 mutations in mitochondrial tRNA (m.10463 T\>C and m.14687 T\>C)\]. These mutations were frequently detected in this family, although the difference relative to the controls was not statistically significant (*P*\>0.05).

m.8462 T\>C sequence change (homoplasmic state) is located at codon 33 in the outside transmembrane domain of the ATPase 8 gene, and changes a moderate conserved tyrosine, a hydrophilic amino acid, to histidine, a hydrophilic amino acid, modifying the hydropathy index from -0.867 to -1.08. SIFT projected that it tolerated with score of 0.08 and the median sequence conservation was 3.08. This sequence alteration is presented to 14 patients (77.7%) and compared with 2 normal subjects (6.6%) (*P*= 0.0001).

m.8704 A\>C sequence variant (homoplasmic state) is located at amino acid position 60 in transmembrane domain of ATPase 6 gene. It changes a moderate conserved methionine, a hydrophobic amino acid, to valine, a hydrophobic amino acid, which changes the hydropathy index from -0.811 to -0.556. SIFT predicted that it affected protein function with score of 0.03 and median sequence conservation was 4.18. This sequence alteration was in 1 controls.

m.9140 C\>G sequence change (heteroplasmic state) is located at amino acid position 205 in transmembrane domain of ATPase 6 gene. It changes a highly conserved alanine, a hydrophobic amino acid, to glycine, a hydrophobic amino acid, which changes the hydropathy index from 2.82 to 2.44. SIFT predicted that it affected protein function with score of 0.00 and median sequence conservation was 4.18. This sequence alteration was not observed in controls.

m.10530 G\>A sequence variant (heteroplasmic state) is located at amino acid position 21 in transmembrane domain of ND4L gene. It reforms an average conserved valine and a hydrophobic amino acid, to methionine; a hydrophobic amino acid, which changes the hydropathy index from 0.389 to 0.133. SIFT predicted that it affected protein function with score of 0.00, and the median sequence conservation was 4.32. The sequence fluctuation was seen in 1 control. Moreover, the results indicate that there are two different point mutations in tRNA genes, as explained earlier ([@R15]). These mutations were discovered among 14 patients (P1 to P14) and their mothers, as well.

m.10463 T\>C sequence change is located at a moderate conserved region of the acceptor stem of tRNA arginine. This mutation was not observed in healthy control subjects but was previously reported as a polymorphism ([@R16]).

m.14687 T\>C sequence change is located at a highly conserved region of the T-loop of tRNA glutamate. It was not detected in controls and was previously reported as pathologic ([@R17]).

Discussion
==========

LQTS is a disorder resulting from a prolongation in ventricular repolarization and increases the risk of developing torsades de pointes and sudden cardiac death ([@R6]). The main criteria for clinical diagnosis of LQTS are a prolonged QTc value exceeding 450 ms and documented syncope episodes ([@R18]). On the condition that mitochondrial mutations arise in LQTS, it might be particularly noteworthy in under pressure states, which extend the rate of energy utilization ([@R19]).

Through examinations and detailed analysis of the mitochondrial genome of the family, 6 mutations of maternal transmission were discovered. In this family, three affected mothers (P1, P2 and P4) transmitted their mitochondrial hetero/homoplasmic mutations to their children (Figure [1C](#F1){ref-type="fig"}). All of their children are affected and have these mutations. It is realized that the m.9140 C\>G (ATPase 6 gene) and m.10530 G\>A (ND4L gene) mutations are pathogenic because of the following reasons: 1. these mutations alter residues in the sequences of their proteins, which are highly and moderately conserved during evolution, respectively and are located in structurally/functionally important regions; 2. these mutations were never reported as neutral polymorphisms and were not detected in normal individuals from different ethnic backgrounds; 3. the mutations were heteroplasmic in the lymphocyte cells analyzed, and heteroplasmy is a common feature of pathogenic mtDNA mutation; 4. the chemical distances of an alanine amino acid with a glycine amino acid (A205G) and a valine amino acid with a methionine amino acid (V21M) are relatively large (D=60 and D=21, respectively); 5. it is predicted that SIFT has influence on the function of proteins. SIFT is considered as a sequence homology-based tool that distinguishes intolerant from tolerant amino acid substitutions, and predicts whether an amino acid substitution in a protein will have a phenotypic impact or not; 6. the mutations change the hydropathy profile at a hydrophobic region.

By investigating seven tRNA genes, we found two mutations in tRNA^Arg^ (T10463C) and tRNA^Glu^ (T14687C) which have been discussed before ([@R13], [@R20] - [@R22]) (Figure [3](#F3){ref-type="fig"}). Among the control subjects the mutations were not noticed; T14687C is particularly located in a highly conserved region that may be one of several predisposing factors for LQTS.

Our result showed that the mitochondrial mutations in LQTS patients were higher than in control cases (*P*=0.0001). According to the statistics, the significant correlation between QTc (ms) and age of LQTS patients is (r= 0.737) (Figure [4](#F4){ref-type="fig"}). Hence, although the sample size (LQTS patients) is relatively small, the results of the research reveal that mitochondrial mutations might increase QTc as the patients grow older; moreover, they increase the gravity of LQTS.

Our data suggest that these mitochondrial mutations in a family with LQTS might not have caused the onset of the disease but had secondary effects. This phenomenon could be due to the sensitivity of the heart to defects in the mitochondrial respiratory chain (OXPHOS) and energy production ([@R23]). The substitutions might be due to either polymorphism or mutation, however, in order to validate further studies are necessary which consider other criteria with various sample sizes. It is possible that mutations in mtDNA could constitute a predisposing factor that in combination with nuclear mutations and environmental risk factors may trigger the sudden cardiac death.
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###### 

SSCP primer sequences and PCR conditions

  Primer sequence           Nucleotide position   Tm (°C)   Size (bp)   Fragment
  ------------------------- --------------------- --------- ----------- -----------
  F CTACGGTCAATGCTCTGAAA    8161 - 8180           57        444         ATPase8
  R AAATAGAATGATCAGTACTG    8605 - 8586                                 
  F TCTCTTATACTAGTATCCTT    8731-8750             57        319         ATPase6-1
  R CCAATTAGGTGCATGAGTAG    9050-9031                                   
  F ACAATTCTAATTCTACTGAC    9106 - 9125           57        133         ATPase6-2
  R TACTATATGATAGGCATGTGA   9239 - 9216                                 
  F TCTGGCCTATGAGTGACTAC    10361-10380           57        179         tRNA^Arg^
  R GAGCGATATACTAGTATTCC    10540- 10521                                
  F ACCACACCGCTAACAATCAG    14561-14580           57        279         tRNA^Gln^
  R TTCATCATGCGGAGATGTTG    14840 -14821                                

###### 

Summery of mutations identified in the study subjects

  Gene       NT change   AA change    Novel/Rept   Number of controls   Hetero/Homo   *P*-Value
  ---------- ----------- ------------ ------------ -------------------- ------------- -----------
  ATPase8    T8462C      Tyr to His   Novel        0                    Homo          0.0001
  ATPase6    A8704G      Met to Val   Novel        1                    Homo          0.0001
  ATPase6    C9140G      Ala to Gly   Novel        0                    Hetero        0.0001
  tRNA-Arg   T10463C     Noncoding    Rept         2                    Homo          0.0001
  ND4L       G10530A     Val to Met   Novel        0                    Hetero        0.0001
  tRNA-Glu   T14687C     Noncoding    Rept         1                    Homo          0.0001
